- Home
- DRMA vs SNES Comparison
DRMA vs SNES Comparison
Compare DRMA & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- SNES
- Stock Information
- Founded
- DRMA 2014
- SNES 2004
- Country
- DRMA United States
- SNES United States
- Employees
- DRMA N/A
- SNES N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- DRMA Health Care
- SNES Industrials
- Exchange
- DRMA Nasdaq
- SNES Nasdaq
- Market Cap
- DRMA 2.2M
- SNES 2.3M
- IPO Year
- DRMA 2021
- SNES 2016
- Fundamental
- Price
- DRMA $1.06
- SNES $3.16
- Analyst Decision
- DRMA Strong Buy
- SNES Strong Buy
- Analyst Count
- DRMA 1
- SNES 1
- Target Price
- DRMA $6.00
- SNES $10.00
- AVG Volume (30 Days)
- DRMA 588.9K
- SNES 311.7K
- Earning Date
- DRMA 11-13-2024
- SNES 11-12-2024
- Dividend Yield
- DRMA N/A
- SNES N/A
- EPS Growth
- DRMA N/A
- SNES N/A
- EPS
- DRMA N/A
- SNES N/A
- Revenue
- DRMA N/A
- SNES $1,651,000.00
- Revenue This Year
- DRMA N/A
- SNES $91.45
- Revenue Next Year
- DRMA N/A
- SNES $101.31
- P/E Ratio
- DRMA N/A
- SNES N/A
- Revenue Growth
- DRMA N/A
- SNES 38.16
- 52 Week Low
- DRMA $1.03
- SNES $1.90
- 52 Week High
- DRMA $13.35
- SNES $21.40
- Technical
- Relative Strength Index (RSI)
- DRMA 41.39
- SNES 56.47
- Support Level
- DRMA $1.03
- SNES $2.32
- Resistance Level
- DRMA $1.43
- SNES $5.00
- Average True Range (ATR)
- DRMA 0.14
- SNES 0.52
- MACD
- DRMA -0.01
- SNES 0.13
- Stochastic Oscillator
- DRMA 11.90
- SNES 35.66
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.